|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Raghavan D, Shipley WU, Garnick MB,
Russell PJ and Richie JP: Biology and management of bladder cancer.
N Engl J Med. 322:1129–1138. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stenzl A, Cowan NC, De Santis M, Jakse G,
Kuczyk MA, Merseburger AS, Ribal MJ, Sherif A and Witjes JA: The
updated EAU guidelines on muscle-invasive and metastatic bladder
cancer. Eur Urol. 55:815–825. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kurian A, Lee J and Born A: Urothelial
bladder cancer with cavitary lung metastases. Can Respir J.
18:e46–e47. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hill RP, Marie-Egyptienne DT and Hedley
DW: Cancer stem cells, hypoxia and metastasis. Semin Radiat Oncol.
19:106–111. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Adams JM, Difazio LT, Rolandelli RH, Luján
JJ, Haskó G, Csóka B, Selmeczy Z and Németh ZH: HIF-1: A key
mediator in hypoxia. Acta Physiol Hung. 96:19–28. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Joseph JV, Conroy S, Pavlov K, Sontakke P,
Tomar T, Eggens-Meijer E, Balasubramaniyan V, Wagemakers M, den
Dunnen WF and Kruyt FA: Hypoxia enhances migration and invasion in
glioblastoma by promoting a mesenchymal shift mediated by the
HIF1α-ZEB1 axis. Cancer Lett. 359:107–116. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu K, Ning Z, Zeng J, Fan J, Zhou J, Zhang
T, Zhang L, Chen Y, Gao Y, Wang B, et al: Silibinin inhibits
β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis
via dual-blocking epithelial-mesenchymal transition and stemness.
Cell Signal. 25:2625–2633. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kenney PA, Wszolek MF, Rieger-Christ KM,
Neto BS, Gould JJ, Harty NJ, Mosquera JM, Zeheb R, Loda M, Darling
DS, et al: Novel ZEB1 expression in bladder tumorigenesis. BJU Int.
107:656–663. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang T, Fan J, Wu K, Zeng J, Sun K, Guan
Z, Wang X, Hiesh JT and He D: Roles of HIF-1α in a novel optical
orthotopic spontaneous metastatic bladder cancer animal model. Urol
Oncol. 30:928–935. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Karam JA, Huang S, Fan J, Stanfield J,
Schultz RA, Pong RC, Sun X, Mason RP, Xie XJ, Niu G, et al:
Upregulation of TRAG3 gene in urothelial carcinoma of the bladder.
Int J Cancer. 128:2823–2832. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Witjes JA, Compérat E, Cowan NC, De Santis
M, Gakis G, Lebret T, Ribal MJ, Van der Heijden AG and Sherif A;
European Association of Urology, : EAU guidelines on
muscle-invasive and metastatic bladder cancer: Summary of the 2013
guidelines. Eur Urol. 65:778–792. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schned AR, Andrew AS, Marsit CJ, Kelsey
KT, Zens MS and Karagas MR: Histological classification and stage
of newly diagnosed bladder cancer in a population-based study from
the Northeastern United States. Scand J Urol Nephrol. 42:237–242.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Murai T, Yamada S, Fuchs BC, Fujii T,
Nakayama G, Sugimoto H, Koike M, Fujiwara M, Tanabe KK and Kodera
Y: Epithelial-to-mesenchymal transition predicts prognosis in
clinical gastric cancer. J Surg Oncol. 109:684–689. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pouysségur J, Dayan F and Mazure NM:
Hypoxia signalling in cancer and approaches to enforce tumour
regression. Nature. 441:437–443. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Denko NC: Hypoxia, HIF1 and glucose
metabolism in the solid tumour. Nat Rev Cancer. 8:705–713. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Krishnamachary B, Zagzag D, Nagasawa H,
Rainey K, Okuyama H, Baek JH and Semenza GL: Hypoxia-inducible
factor-1-dependent repression of E-cadherin in von Hippel-Lindau
tumor suppressor-null renal cell carcinoma mediated by TCF3,
ZFHX1A, and ZFHX1B. Cancer Res. 66:2725–2731. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rohwer N, Lobitz S, Daskalow K, Jöns T,
Vieth M, Schlag PM, Kemmner W, Wiedenmann B, Cramer T and Höcker M:
HIF-1alpha determines the metastatic potential of gastric cancer
cells. Br J Cancer. 100:772–781. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Deniz H, Karakök M, Yagci F and Güldür ME:
Evaluation of relationship between HIF-1alpha immunoreactivity and
stage, grade, angiogenic profile and proliferative index in bladder
urothelial carcinomas. Int Urol Nephrol. 42:103–107. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Meng X, Kong DH, Li N, Zong ZH, Liu BQ, Du
ZX, Guan Y, Cao L and Wang HQ: Knockdown of BAG3 induces
epithelial-mesenchymal transition in thyroid cancer cells through
ZEB1 activation. Cell Death Dis. 5:e10922014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu K, Fan J, Zhang L, Ning Z, Zeng J, Zhou
J, Li L, Chen Y, Zhang T, Wang X, et al: PI3K/Akt to
GSK3β/β-catenin signaling cascade coordinates cell colonization for
bladder cancer bone metastasis through regulating ZEB1
transcription. Cell Signal. 24:2273–2282. 2012. View Article : Google Scholar : PubMed/NCBI
|
